Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,074
Closed -$264K 1397
2022
Q3
$264K Buy
1,074
+14
+1% +$3.78K 0.01% 859
2022
Q2
$262K Buy
1,060
+340
+47% +$91.8K 0.01% 845
2022
Q1
$238K Buy
720
+159
+28% +$48.9K 0.01% 887
2021
Q4
$201K Sell
561
-1,034
-65% -$349K 0.01% 860
2021
Q3
$519K Sell
1,595
-89
-5% -$30.1K 0.02% 584
2021
Q2
$526K Sell
1,684
-82
-5% -$25.2K 0.02% 613
2021
Q1
$563K Sell
1,766
-20
-1% -$6.4K 0.02% 595
2020
Q4
$579K Sell
1,786
-73
-4% -$20.2K 0.02% 519
2020
Q3
$515K Sell
1,859
-27
-1% -$7.78K 0.02% 494
2020
Q2
$456K Buy
1,886
+919
+95% +$185K 0.02% 443
2020
Q1
$140K Buy
967
+184
+23% +$30.5K 0.01% 683
2019
Q4
$134K Buy
+783
New +$145K 0.01% 751

Other funds holding ABMD

Vestcor Inc's ABMD Position: Q4 2022 in Review

Vestcor Inc sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,074 shares — an estimated $264K sold.

Vestcor Inc first reported a position in ABMD in Q4 2019 and held it in 12 quarters. The position peaked at $579K in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Vestcor Inc reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Vestcor Inc sold 1,074 Abiomed Inc shares in Q4 2022, an estimated $264K.
  • Vestcor Inc first reported a position in Abiomed Inc in Q4 2019 and held it in 12 quarters.
  • Vestcor Inc's Abiomed Inc position peaked at $579K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Vestcor Inc's 13F filing for Q4 2022, filed 15 Feb 2023.